πŸ‡ΊπŸ‡Έ FDA
Patent

US 8101745

Lung-targeted drugs

granted A61KA61K47/543A61P

Quick answer

US patent 8101745 (Lung-targeted drugs) held by The Regents of the University of California expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K47/543, A61P, A61P11/00, A61P31/00